Trial Information
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
Inclusion Criteria:
1. All children who present at Packard hospital with a new diagnosis or
relapse of acute leukemia will be eligible. There is no bias in regards to age range,
gender or ethnic background.
2. Signed informed consent
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Gene Expression
Outcome Time Frame:
days 0, 8, 22 or 29
Safety Issue:
No
Principal Investigator
Norman James Lacayo
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
PEDSHEM0001
NCT ID:
NCT01108497
Start Date:
July 2001
Completion Date:
Related Keywords:
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |